Arrowhead Pharmaceuticals Inc (ARWR)
Pretax margin
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 54,944 | -153,975 | -152,274 | -648,886 | -612,460 | -548,652 | -478,058 | -303,386 | -206,491 | -179,658 | -148,321 | -151,631 | -172,709 | -153,924 | -111,802 | -182,986 | -140,846 | -125,904 | -109,591 | -102,609 |
| Revenue (ttm) | US$ in thousands | 829,448 | 596,565 | 568,798 | 26,089 | 27,140 | 19,648 | 35,473 | 181,740 | 240,735 | 256,213 | 272,800 | 278,338 | 243,231 | 249,939 | 263,418 | 144,424 | 138,288 | 107,638 | 89,123 | 79,841 |
| Pretax margin | 6.62% | -25.81% | -26.77% | -2,487.20% | -2,256.67% | -2,792.41% | -1,347.67% | -166.93% | -85.78% | -70.12% | -54.37% | -54.48% | -71.01% | -61.58% | -42.44% | -126.70% | -101.85% | -116.97% | -122.97% | -128.52% |
September 30, 2025 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $54,944K ÷ $829,448K
= 6.62%